Trinity Biotech | TRIB - Net Income


Trinity Biotech reported $-5.14M in Net Income for its fiscal quarter ending in September of 2025.





Net Income Change Date
Abbott USD 1.08B 699M Mar/2026
Bayer EUR -3.76B 2.79B Dec/2025
Bio-Rad Laboratories USD -341.9M 659.7M Sep/2025
EDAP TMS EUR -5.01M 586K Sep/2025
J&J USD 5.24B 119M Mar/2026
Mesa Laboratories USD -1.68M 5.1M Dec/2024
OraSure Technologies USD -19.29M 5.57M Dec/2025
Plus Therapeutics USD -5.71M 1.29M Dec/2025
Roche Holding CHF 5.47B 1.76B Dec/2025
Siemens EUR 2.03B 411M Dec/2025
Surmodics USD -5.32M 6.22M Jun/2025
Thermo Fisher Scientific USD 1.65B 313M Mar/2026
Tosoh JPY 17.25B 16.4B Dec/2025
Trinity Biotech USD -5.14M 11.82M Sep/2025
Veracyte USD 41.15M 22.01M Dec/2025